223 related articles for article (PubMed ID: 14719130)
1. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
[TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein(a) phenotypes as markers of genetic susceptibility for cardiovascular risk in occupational medicine].
Mennoia NV; Gazzaruso C; Geroldi D; Candura SM
G Ital Med Lav Ergon; 1999; 21(3):206-17. PubMed ID: 10771732
[TBL] [Abstract][Full Text] [Related]
5. Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease.
Dirisamer A; Widhalm H; Aldover-Macasaet E; Molzer S; Widhalm K
Acta Paediatr; 2008 Dec; 97(12):1653-7. PubMed ID: 18684164
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
[TBL] [Abstract][Full Text] [Related]
7. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
[TBL] [Abstract][Full Text] [Related]
8. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; D'Angelo A; Montagna L; Bruni AC; Geroldi D
Neurosci Lett; 2004 Feb; 357(1):45-8. PubMed ID: 15036610
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
[TBL] [Abstract][Full Text] [Related]
12. A pentanucleotide repeat polymorphism (TTTTA) in the apolipoprotein (a) gene--its distribution and its association with the risk of cardiovascular disease.
Calò CM; Varesi L; Memmi M; Moral P; Vona G
Coll Antropol; 2003 Jun; 27(1):105-15. PubMed ID: 12974138
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between lipoprotein A, apolipoprotein A and their isoforms in parents and children].
Ferrer Lorente B; Dalmau Serra J; Falcó Couchoud C; Estellés Cortés A; España Furió F; Aznar Lucea J
An Esp Pediatr; 1998 Jun; 48(6):587-92. PubMed ID: 9662841
[TBL] [Abstract][Full Text] [Related]
14. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
15. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
[TBL] [Abstract][Full Text] [Related]
16. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
Shen GX; Mymin D; Dembinski T; Krahn A; Angel A
Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
[TBL] [Abstract][Full Text] [Related]
19. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.
Seed M; Hoppichler F; Reaveley D; McCarthy S; Thompson GR; Boerwinkle E; Utermann G
N Engl J Med; 1990 May; 322(21):1494-9. PubMed ID: 2139920
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
